Podcast Episodes

Back to Search
Bispecific Antibodies in the Management of Multiple Myeloma
Bispecific Antibodies in the Management of Multiple Myeloma

Season 1

Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bisp…

1 year, 9 months ago

Short Long
View Episode
Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Season 1

Dr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphi…

1 year, 9 months ago

Short Long
View Episode
Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer
Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer

Season 1

Dr Adam M Brufsky from UPMC Hillman Cancer Center in Pittsburgh summarizes the history of and modern advances in treating localized HER2-pos…

1 year, 9 months ago

Short Long
View Episode
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia

Season 1

Drs Naval Daver and Courtney D DiNardo, both from The University of Texas MD Anderson Cancer Center in Houston, summarize the clinical progr…

1 year, 9 months ago

Short Long
View Episode
Virtual Case Library: Metastatic Triple-Negative Breast Cancer
Virtual Case Library: Metastatic Triple-Negative Breast Cancer

Season 1

Drs Rita Nanda, Sara M Tolaney, Julia Foldi, Laura Huppert and Saba Shaikh discuss available and emerging research, patient cases from parti…

1 year, 9 months ago

Short Long
View Episode
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition

Season 1

Dr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-…

1 year, 10 months ago

Short Long
View Episode
Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer

Season 1

Prof Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategi…

1 year, 10 months ago

Short Long
View Episode
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series

Season 1

Dr Ruben A Mesa from Wake Forest University School of Medicine in Winston-Salem, North Carolina, discusses recent updates on available and n…

1 year, 10 months ago

Short Long
View Episode
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria

Season 1

Dr Carlos de Castro, Prof Alexander Röth and Dr Ilene Weitz summarize the biology of paroxysmal nocturnal hemoglobinuria, current treatment …

1 year, 10 months ago

Short Long
View Episode
Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium
Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium

Season 1

Dr Emmanuel Antonarakis from the University of Minnesota in Minneapolis reviews research findings presented at the 2024 Genitourinary Cancer…

1 year, 10 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us